XenoPort to Present at the RBC Capital Markets’ Global Healthcare Conference
February 18 2014 - 1:06PM
Business Wire
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will
provide access via the World Wide Web to its presentation at the
RBC Capital Markets’ Global Healthcare Conference. The live
presentation will occur at 11:35 a.m. Pacific Time (2:35 p.m.
Eastern Time) on Tuesday, February 25, 2014. A replay of the
presentation will also be available.
To access the live presentation via the Web, please go to
www.XenoPort.com. Please connect to the Web site at least 15
minutes prior to the live presentation to ensure adequate time for
any software downloads that may be necessary to listen to the
Webcast.
A replay of the Webcast can be accessed for a minimum of one
month and will be available approximately 24 hours after the live
presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on
developing and commercializing a portfolio of internally discovered
product candidates for the potential treatment of neurological
disorders. XenoPort is currently commercializing HORIZANT®
(gabapentin enacarbil) Extended-Release Tablets in the United
States and developing its novel fumaric acid ester product
candidate, XP23829, as a potential treatment for psoriasis and/or
relapsing forms of multiple sclerosis. REGNITE® (gabapentin
enacarbil) Extended-Release Tablets is being marketed in Japan by
Astellas Pharma Inc. XenoPort's pipeline of product candidates also
includes potential treatments for patients with spasticity related
to spinal cord injury and Parkinson's disease. To learn more about
XenoPort, please visit the Web site at www.XenoPort.com.
HORIZANT, REGNITE and XENOPORT are registered trademarks of
XenoPort, Inc.
XNPT2G
XenoPort, Inc.Jackie Cossmon, 408-616-7220ir@XenoPort.com
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Sep 2023 to Sep 2024